PTEN hamartoma tumor syndrome: genes and variants
Explore variant evidence for PTEN hamartoma tumor syndrome across 1 analyzed protein (PTEN). Linked ClinVar records include 147 pathogenic or likely pathogenic variants, 455 variants of uncertain significance and 95 with conflicting classifications.
Coverage includes proteins already analyzed in CATVariant, not every gene involved in this condition. Database links are associations, not an assessment of clinical gene–disease validity. Computable evidence prioritizes variants for expert review and does not reclassify them. Counts refer to the selected disease label.
Data updated 2026-10-15. Automated aggregation, not a clinical review date.
Download variant evidence (CSV)
Genes linked to PTEN hamartoma tumor syndrome
PTEN: Phosphatidylinositol 3,4,5-trisphosphate 3-phosphatase and dual-specificity protein phosphatase PTEN
A lipid and protein phosphatase that removes phosphate groups from signaling molecules, especially PIP3. By opposing the PI3K-AKT pathway, it limits cell growth and survival signals, and PTEN variants are associated with Cowden syndrome and multiple cancers.
147 ClinVar pathogenic / likely pathogenic and 550 uncertain variants in PTEN have source records linked to PTEN hamartoma tumor syndrome. Association strength is not clinical gene validity.
Where PTEN hamartoma tumor syndrome variants cluster
- PTEN Phosphatase tensin-type (positions 14–185): 114 of 144 ClinVar pathogenic / likely pathogenic variants, 1.9× more than its size predicts (a length-based count, not a validated hotspot).
ClinVar pathogenic and likely pathogenic variants linked to PTEN hamartoma tumor syndrome
| Variant | Position | Protein part | Clinical label |
|---|---|---|---|
| PTEN D24H | 24 | Phosphatase tensin-type | Pathogenic / likely pathogenic (★★★) |
| PTEN R130Q | 130 | Phosphatase tensin-type | Pathogenic / likely pathogenic (★★★) |
| PTEN S170R | 170 | Phosphatase tensin-type | Pathogenic / likely pathogenic (★★★) |
| PTEN R173C | 173 | Phosphatase tensin-type | Pathogenic / likely pathogenic (★★★) |
| PTEN Y174C | 174 | Phosphatase tensin-type | Pathogenic / likely pathogenic (★★★) |
| PTEN G209E | 209 | C2 tensin-type | Pathogenic / likely pathogenic (★★★) |
| PTEN T277I | 277 | C2 tensin-type | Pathogenic / likely pathogenic (★★★) |
| PTEN R15T | 15 | Phosphatase tensin-type | Pathogenic / likely pathogenic (★★★) |
| PTEN R15K | 15 | Phosphatase tensin-type | Pathogenic / likely pathogenic (★★★) |
| PTEN Y27S | 27 | Phosphatase tensin-type | Pathogenic / likely pathogenic (★★★) |
| PTEN Y27C | 27 | Phosphatase tensin-type | Pathogenic / likely pathogenic (★★★) |
| PTEN M35R | 35 | Phosphatase tensin-type | Pathogenic / likely pathogenic (★★★) |
| PTEN M35V | 35 | Phosphatase tensin-type | Pathogenic / likely pathogenic (★★★) |
| PTEN G36E | 36 | Phosphatase tensin-type | Pathogenic / likely pathogenic (★★★) |
| PTEN G36R | 36 | Phosphatase tensin-type | Pathogenic / likely pathogenic (★★★) |
| PTEN R47G | 47 | Phosphatase tensin-type | Pathogenic / likely pathogenic (★★★) |
| PTEN R47K | 47 | Phosphatase tensin-type | Pathogenic / likely pathogenic (★★★) |
| PTEN H93P | 93 | Phosphatase tensin-type | Pathogenic / likely pathogenic (★★★) |
| PTEN H93R | 93 | Phosphatase tensin-type | Pathogenic / likely pathogenic (★★★) |
| PTEN P96L | 96 | Phosphatase tensin-type | Pathogenic / likely pathogenic (★★★) |
| PTEN D107Y | 107 | Phosphatase tensin-type | Pathogenic / likely pathogenic (★★★) |
| PTEN D107V | 107 | Phosphatase tensin-type | Pathogenic / likely pathogenic (★★★) |
| PTEN W111R | 111 | Phosphatase tensin-type | Pathogenic / likely pathogenic (★★★) |
| PTEN H123D | 123 | Phosphatase tensin-type | Pathogenic / likely pathogenic (★★★) |
| PTEN H123R | 123 | Phosphatase tensin-type | Pathogenic / likely pathogenic (★★★) |
| PTEN C124R | 124 | Phosphatase tensin-type | Pathogenic / likely pathogenic (★★★) |
| PTEN R130P | 130 | Phosphatase tensin-type | Pathogenic / likely pathogenic (★★★) |
| PTEN R130G | 130 | Phosphatase tensin-type | Pathogenic / likely pathogenic (★★★) |
| PTEN G132D | 132 | Phosphatase tensin-type | Pathogenic / likely pathogenic (★★★) |
| PTEN M134I | 134 | Phosphatase tensin-type | Pathogenic / likely pathogenic (★★★) |
| PTEN C136Y | 136 | Phosphatase tensin-type | Pathogenic / likely pathogenic (★★★) |
| PTEN C136W | 136 | Phosphatase tensin-type | Pathogenic / likely pathogenic (★★★) |
| PTEN Q171R | 171 | Phosphatase tensin-type | Pathogenic / likely pathogenic (★★★) |
| PTEN Q171E | 171 | Phosphatase tensin-type | Pathogenic / likely pathogenic (★★★) |
| PTEN Y174N | 174 | Phosphatase tensin-type | Pathogenic / likely pathogenic (★★★) |
| PTEN G209R | 209 | C2 tensin-type | Pathogenic / likely pathogenic (★★★) |
| PTEN D252G | 252 | C2 tensin-type | Pathogenic / likely pathogenic (★★★) |
| PTEN T277R | 277 | C2 tensin-type | Pathogenic / likely pathogenic (★★★) |
| PTEN L23V | 23 | Phosphatase tensin-type | Pathogenic / likely pathogenic (★★★) |
| PTEN I50T | 50 | Phosphatase tensin-type | Pathogenic / likely pathogenic (★★★) |
| PTEN K66N | 66 | Phosphatase tensin-type | Pathogenic / likely pathogenic (★★★) |
| PTEN Y155C | 155 | Phosphatase tensin-type | Pathogenic / likely pathogenic (★★★) |
| PTEN G165R | 165 | Phosphatase tensin-type | Pathogenic / likely pathogenic (★★★) |
| PTEN Y177C | 177 | Phosphatase tensin-type | Pathogenic / likely pathogenic (★★★) |
| PTEN P246L | 246 | C2 tensin-type | Pathogenic / likely pathogenic (★★★) |
| PTEN G20V | 20 | Phosphatase tensin-type | Pathogenic / likely pathogenic (★★★) |
| PTEN D22H | 22 | Phosphatase tensin-type | Pathogenic / likely pathogenic (★★★) |
| PTEN N31D | 31 | Phosphatase tensin-type | Pathogenic / likely pathogenic (★★★) |
| PTEN A34P | 34 | Phosphatase tensin-type | Pathogenic / likely pathogenic (★★★) |
| PTEN P38L | 38 | Phosphatase tensin-type | Pathogenic / likely pathogenic (★★★) |
| PTEN H61D | 61 | Phosphatase tensin-type | Pathogenic / likely pathogenic (★★★) |
| PTEN H61R | 61 | Phosphatase tensin-type | Pathogenic / likely pathogenic (★★★) |
| PTEN L70P | 70 | Phosphatase tensin-type | Pathogenic / likely pathogenic (★★★) |
| PTEN C71Y | 71 | Phosphatase tensin-type | Pathogenic / likely pathogenic (★★★) |
| PTEN P95L | 95 | Phosphatase tensin-type | Pathogenic / likely pathogenic (★★★) |
| PTEN C105Y | 105 | Phosphatase tensin-type | Pathogenic / likely pathogenic (★★★) |
| PTEN L112V | 112 | Phosphatase tensin-type | Pathogenic / likely pathogenic (★★★) |
| PTEN K125E | 125 | Phosphatase tensin-type | Pathogenic / likely pathogenic (★★★) |
| PTEN T131I | 131 | Phosphatase tensin-type | Pathogenic / likely pathogenic (★★★) |
| PTEN H141P | 141 | Phosphatase tensin-type | Pathogenic / likely pathogenic (★★★) |
Showing 60 of 147.
Uncertain variants prioritized for review in PTEN hamartoma tumor syndrome
| Variant | Position | Protein part | Clinical label | Evidence |
|---|---|---|---|---|
| PTEN G165E | 165 | Phosphatase tensin-type | Conflicting reports (★) | +6: 2 other pathogenic changes within 3 positions; G165R at the same position is pathogenic; REVEL 0.960 |
| PTEN R173S | 173 | Phosphatase tensin-type | Conflicting reports (★) | +6: 10 other pathogenic changes within 3 positions; R173C at the same position is pathogenic; REVEL 0.975 |
| PTEN D22Y | 22 | Phosphatase tensin-type | Conflicting reports (★) | +6: 8 other pathogenic changes within 3 positions; D22H at the same position is pathogenic; REVEL 0.957 |
| PTEN Y46C | 46 | Phosphatase tensin-type | Conflicting reports (★) | +6: 6 other pathogenic changes within 3 positions; Y46N at the same position is pathogenic; REVEL 0.985 |
| PTEN D22G | 22 | Phosphatase tensin-type | Conflicting reports (★) | +6: 8 other pathogenic changes within 3 positions; D22H at the same position is pathogenic; REVEL 0.868 |
| PTEN C71F | 71 | Phosphatase tensin-type | Conflicting reports (★) | +6: 4 other pathogenic changes within 3 positions; C71Y at the same position is pathogenic; REVEL 0.958 |
| PTEN N31I | 31 | Phosphatase tensin-type | Uncertain (★) | +6: 3 other pathogenic changes within 3 positions; N31D at the same position is pathogenic; REVEL 0.914 |
| PTEN T277K | 277 | C2 tensin-type | Uncertain (★★) | +6: 4 other pathogenic changes within 3 positions; T277R at the same position is pathogenic; REVEL 0.980 |
| PTEN W274S | 274 | C2 tensin-type | Uncertain (★) | +6: 4 other pathogenic changes within 3 positions; W274L at the same position is pathogenic; REVEL 0.885 |
| PTEN T131A | 131 | Phosphatase tensin-type | Uncertain (★) | +6: 15 other pathogenic changes within 3 positions; T131I at the same position is pathogenic; REVEL 0.977 |
| PTEN H93L | 93 | Phosphatase tensin-type | Uncertain (★) | +6: 11 other pathogenic changes within 3 positions; H93D at the same position is pathogenic; REVEL 0.961 |
| PTEN W274C | 274 | C2 tensin-type | Uncertain (★) | +6: 4 other pathogenic changes within 3 positions; W274L at the same position is pathogenic; REVEL 0.859 |
| PTEN K66E | 66 | Phosphatase tensin-type | Uncertain (★) | +6: 4 other pathogenic changes within 3 positions; K66N at the same position is pathogenic; REVEL 0.907 |
| PTEN K6T | 6 | Uncertain (★★) | +6: 2 other pathogenic changes within 3 positions; K6E at the same position is pathogenic; REVEL 0.824 | |
| PTEN I67L | 67 | Phosphatase tensin-type | Uncertain (★) | +6: 5 other pathogenic changes within 3 positions; I67R at the same position is pathogenic; REVEL 0.805 |
| PTEN W274G | 274 | C2 tensin-type | Uncertain (★) | +6: 4 other pathogenic changes within 3 positions; W274L at the same position is pathogenic; REVEL 0.820 |
| PTEN Y16H | 16 | Phosphatase tensin-type | Uncertain (★★★) | +6: 6 other pathogenic changes within 3 positions; Y16D at the same position is pathogenic; REVEL 0.866 |
| PTEN D19G | 19 | Phosphatase tensin-type | Uncertain (★★) | +6: 4 other pathogenic changes within 3 positions; D19V at the same position is pathogenic; REVEL 0.802 |
Which prediction tools work for PTEN hamartoma tumor syndrome
Observed separation of ClinVar pathogenic / likely pathogenic from benign / likely benign variants (AUROC × 100). This benchmark is not a clinical recommendation.
- ESM1b (LLR): 100 out of 100
- AlphaMissense: 100 out of 100
- DMS / MaveDB: 58 out of 100
Same protein, different disease
- Cowden syndrome also has ClinVar records linked to PTEN variants; they fall in the same places as the PTEN hamartoma tumor syndrome variants (41 pathogenic / likely pathogenic).
- Macrocephaly-autism syndrome also has ClinVar records linked to PTEN variants; they fall in the same places as the PTEN hamartoma tumor syndrome variants (13 pathogenic / likely pathogenic).
- Familial meningioma also has ClinVar records linked to PTEN variants; they fall in the same places as the PTEN hamartoma tumor syndrome variants (3 pathogenic / likely pathogenic).
Diseases related to PTEN hamartoma tumor syndrome
- Cowden syndrome, also linked to PTEN
- Hereditary breast cancer, also linked to PTEN
- Macrocephaly-autism syndrome, also linked to PTEN
- Glioma susceptibility, also linked to PTEN
- Familial meningioma, also linked to PTEN
- Prostate cancer, also linked to PTEN
- Endometrial carcinoma, also linked to PTEN
- Thyroid cancer, nonmedullary, also linked to PTEN
- Melanoma, also linked to PTEN
- Head and neck squamous cell carcinoma, also linked to PTEN
- Prostate cancer, hereditary, also linked to PTEN
Frequently asked questions
Which genes have records linked to PTEN hamartoma tumor syndrome?
This view contains 1 analyzed proteins: PTEN. Links come from clinical records and association databases. They do not imply that every listed gene is a validated cause, and missing genes may not yet be analyzed.
What do the clinical classifications mean?
Linked records include 147 pathogenic or likely pathogenic variants, 455 variants of uncertain significance and 95 with conflicting classifications. Labels summarize source records; multi-condition records may not make a separate assertion for this disease. Check the original record and review status.
Does the evidence score change a VUS classification?
No. 18 VUS or conflicting variants reach the likely-pathogenic points range on the computable criteria available here. This is a research prioritization signal, not a clinical classification. Patient, family and other required evidence may be missing.
Can I download the variant evidence?
Download the CSV for all 722 variants in the selected disease scope, including clinical labels, review status, evidence criteria, predictor scores, functional measurements and population frequency where available.
About this data
Variant–disease links come from ClinVar, Open Targets and UniProt, pooled from eligible public CATVariant analyses of each human protein. Evidence scores use the ACMG/AMP Bayesian points scale with computable criteria only (position among known disease variants, rarity in gnomAD, calibrated predictors, deep mutational scanning); there is no family or patient data, so they prioritise variants for expert review and never classify them.
Download every variant as CSV · Browse all diseases · Methods · About the Center